 Home > Biochemistry News > Biotechnology News > BridGene reached a partnership to innovate phenotypic screening for breast cancer difficult drug targets

BridGene reached a partnership to innovate phenotypic screening for breast cancer difficult drug targets

 Last Update: 2021-12-26
 Source: Internet
 Author: User

Tags

cancer peritoneal metastasis

ovarian cyst infertility

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, BridGene Biosciences announced that it has reached a research cooperation agreement with the Peter MacCallum Cancer Center (officially referred to as Peter Mac)

Phenotypic screening is a powerful drug discovery tool that can detect compounds in cell or animal disease models, find those compounds that can cause ideal changes in the phenotype of disease-related cells, and discover new compounds for the treatment of diseases

BridGene's unique IMTAC technology platform can not only discover small molecule ligands for a large number of targets (including "non-drugable" targets) in living cells; it can also be combined with phenotypic screening technology to determine targets that drive phenotypic changes and disease occurrence

▲IMTAC technology platform (picture source: BridGene's official website)

Reference materials:

[1] BridGene Biosciences Announces Research Collaboration with the Peter MacCallum Cancer Centre to Discover Targets and Small Molecule Drug Candidates for Ovarian Cancer.

(WuXi AppTec)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.